University of Aarhus: Insulin Resistance trials

The registry lists 31 Insulin Resistance studies with University of Aarhus as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 1No phase 28(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Ketone Bodies on Insulin SensitivityRecruitingNCT07359625Not applicable
• The TiMeD-T1D ProjectNot yet recruitingNCT07172672Not applicable
• Does Co-administration of Lactate to an Oral Glucose Tolerance Test Lower the Glucose Response?CompletedNCT06265337Not applicable
• Polyamine Treatment in Elderly Patients With Coronary Artery DiseaseCompletedNCT06186102Phase 2
• Metabolic Effects of Four-week Lactate-ketone Ester SupplementationCompletedNCT05917873Not applicable
• Effects of Intermittent Fasting on Insulin Resistance, Cardiac Metabolism, and Cerebral PerfusionCompletedNCT05181267Not applicable
• Mechanisms Behind Severe Insulin Resistance During Pregnancy in Women With Glucose Metabolic Disorders (SIR-MET)Status unknownNCT04924504
• Hormonal and Inflammatory Changes During Pregnancy in Women With Glucose Metabolic Disorders.Status unknownNCT04617405
• Metabolic Effects of Melatonin TreatmentCompletedNCT03859934Phase 1
• Lipolytic Effects of GH in Hypopituitary Patients in VivoCompletedNCT02782208Not applicable
• Substrate Metabolism, Growth Hormone Signaling (GH), and Insulin Sensitivity During GH and Ketone Bodies InfusionCompletedNCT02655263Not applicable
• Substrate Metabolism, Growth Hormone Signaling, and Insulin Sensitivity During FastingCompletedNCT02500095Not applicable
• The Effects of Renal Denervation on Insulin SensitivityCompletedNCT01631370Not applicable
• "Can Soluble-CD163 Discriminate Between Healthy and Unhealthy Obese Individuals?"CompletedNCT01463449
• Long-term Investigation of Resveratrol in ObesityCompletedNCT01412645Not applicable
• The Relationship Between Body Composition and Growth Hormone, SIRT Signaling, Protein Turnover and Insulin SensitivityCompletedNCT01299831Not applicable
• The Effect of Pharmacological Antilipolysis on the Metabolic Effects of GhrelinCompletedNCT01209416Not applicable
• Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) KineticsCompletedNCT01205750Not applicable
• Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth WeightCompletedNCT00971815Not applicable
• Insulin Sensitivity and Metabolism Before and After Treatment in Patients With HypothyroidismTerminatedNCT00770016Not applicable
• Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After TreatmentWithdrawnNCT00699530
• Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's SyndromeTerminatedNCT00682084
• Severe Insulin Resistance in Patients With Type 2 DiabetesCompletedNCT00654056Not applicable
• Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic PatientsCompletedNCT00652379Not applicable
• Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After TreatmentCompletedNCT00647179
• Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone DeficiencyCompletedNCT00646815Not applicable
• Body Composition and Very-Low-Density-Lipoprotein-Triglycerides (VLDL-TG) KineticsCompletedNCT00646698
• Testosterone and Lipolysis, Insulin Sensitivity and Protein MetabolismCompletedNCT00613288Not applicable
• Metabolic Studies- Interactions Between GH and Insulin in GHDACompletedNCT00568568Not applicable
• Ghrelin Decreases Insulin SensitivityCompletedNCT00512525Phase 1
• Effect of Growth Hormone on Insulin Signaling in Muscle TissueCompletedNCT00477997Not applicable